arrow
M

Mohammed Almekhlafi

University of Calgary
H指数:48
被引数:9,192

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient Management After Flow Diversion for Unruptured Intracranial Aneurysms: a Literature Review and DELPHI Consensus

未破裂颅内动脉瘤行血流导向装置治疗后的患者管理:文献综述与德尔菲共识

2025-12-010
PRE
Multiple Health Care Encounters Prior to Diagnosis of Cerebral Venous Thrombosis

在诊断为脑静脉血栓形成之前的多次医疗接触

2025-10-240
OAAI
Literature review and DELPHI consensus on follow-up and retreatment of intracranial aneurysms with intrasaccular devices

文献综述与DELPHI共识:颅内动脉瘤采用囊内介入装置的随访与再次治疗

2025-09-010
PRE
Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT Trial

电话和计算机化认知测试作为急性卒中临床 trial 中次要结局的可行性:AcT Trial 的一项混合方法亚研究

2025-03-120
PRE
Factors Influencing Nerinetide Effect on Clinical Outcome in Patients Without Alteplase Treatment in the ESCAPE-NA1 Trial

影响ESCAPE-NA1试验中未接受阿替普酶治疗患者神经调节蛋白1疗效的临床因素

stroke
IF8.6
2025-01-310
OA
Thrombolysis in Patients With Versus Without Visible Occlusion: A Secondary Analysis From the AcT Trial

与无可见闭塞患者相比,有可见闭塞患者的溶栓治疗:来自AcT试验的二次分析

stroke
IF8.6
2025-01-310
OA
Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial
2025-01-070
PRE
Factors Influencing Nerinetide Effect on Infarct Volume in Patients Without Alteplase in the Randomized ESCAPE-NA1 Trial
STROKE
IF8.9
2025-01-010
PRE
Automatic Matching Algorithms to Identify Eligible Participants for Stroke Trials: A Proof-of-Concept Study

自动匹配算法用于识别卒中试验的合格受试者:一项概念验证研究

2024-12-053
OA
The treatment effect across ASPECTS in acute ischemic stroke: Analysis from the AcT trial
2024-09-110
PRE
Interhospital Transfer for Endovascular Stroke Treatment in Canada: Results From the OPTIMISE Registry

加拿大血管内卒中治疗的医院间转院: 来自OPTIMISE注册中心的结果

STROKE
IF8.9
2024-08-010
PRE
Combining Early Ischemic Change and Collateral Extent for Functional Outcomes After Endovascular Therapy: An Analysis From AcT Trial
STROKE
IF8.9
2024-07-011
PRE
Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial
stroke
IF8.6
2024-05-310
OAAI